Literature DB >> 11323345

Propofol blocks human skeletal muscle sodium channels in a voltage-dependent manner.

G Haeseler1, M Störmer, J Bufler, R Dengler, H Hecker, S Piepenbrock, M Leuwer.   

Abstract

UNLABELLED: Propofol decreases muscle tone in the absence of neuromuscular blocking drugs. This effect probably cannot be attributed solely to central nervous depression. We studied the effects of propofol on heterologously expressed skeletal muscle sodium channels. Our hypothesis was that the decrease in muscle tone may partly be attributed to an interaction of propofol with sarcolemmal sodium channels. Cells were voltage clamped and whole-cell sodium inward currents were recorded in the absence and presence of propofol. When depolarizing pulses to 0 mV were started from a holding potential close to the normal resting potential of muscle (-70 mV), or when a 2.5-s prepulse inducing slow inactivation was applied before the test pulse at -100 mV, a significant reduction in the peak current amplitude was achieved by 10 and 5 microM propofol, respectively (P < 0.001). Half-maximum blocking concentrations with these protocols were 23 and 22 microM. Blocking potency increased at depolarized membrane potentials with the fraction of inactivated channels; the estimated dissociation constant K(d) from the inactivated state was 4.6 microM. These results suggest that propofol significantly blocks sarcolemmal sodium channels at clinically relevant concentrations while maintaining potentials close to the physiological resting potential. IMPLICATIONS: Voltage-gated sodium channels mediate the initiation and propagation of action potentials along the sarcolemma. Results from our study show that those channels are targeted and blocked in a concentration- and voltage-dependent manner by propofol. This mechanism may contribute to the reduction in muscle excitability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323345     DOI: 10.1097/00000539-200105000-00021

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  18 in total

1.  An improved model for the binding of lidocaine and structurally related local anaesthetics to fast-inactivated voltage-operated sodium channels, showing evidence of cooperativity.

Authors:  Martin Leuwer; Gertrud Haeseler; Hartmut Hecker; Johannes Bufler; Reinhard Dengler; Jeffrey K Aronson
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

2.  Block of voltage-operated sodium channels by 2,6-dimethylphenol, a structural analogue of lidocaine's aromatic tail.

Authors:  Gertrud Haeseler; Johannes Bufler; Sarah Merken; Reinhard Dengler; Jeffrey Aronson; Martin Leuwer
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

3.  Effect of intravenous anesthetic propofol on synaptic vesicle exocytosis at the frog neuromuscular junction.

Authors:  Luciana Ferreira Leite; Renato Santiago Gomez; Matheus de Castro Fonseca; Marcus Vinicius Gomez; Cristina Guatimosim
Journal:  Acta Pharmacol Sin       Date:  2010-11-29       Impact factor: 6.150

4.  High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues.

Authors:  G Haeseler; M Karst; N Foadi; S Gudehus; A Roeder; H Hecker; R Dengler; M Leuwer
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

5.  Recovery following propofol-associated brugada electrocardiogram.

Authors:  Justin B Weiner; Elias V Haddad; Satish R Raj
Journal:  Pacing Clin Electrophysiol       Date:  2009-10-10       Impact factor: 1.976

6.  Differential effects of isoflurane and propofol on upper airway dilator muscle activity and breathing.

Authors:  Matthias Eikermann; Atul Malhotra; Philipp Fassbender; Sebastian Zaremba; Amy S Jordan; Shiva Gautam; David P White; Nancy L Chamberlin
Journal:  Anesthesiology       Date:  2008-05       Impact factor: 7.892

7.  Topical antiseptics for the treatment of sore throat block voltage-gated neuronal sodium channels in a local anaesthetic-like manner.

Authors:  Vanessa Buchholz; Martin Leuwer; Jörg Ahrens; Nilufar Foadi; Klaus Krampfl; Gertrud Haeseler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-04-15       Impact factor: 3.000

8.  Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.

Authors:  Carsten Stoetzer; Svenja Reuter; Thorben Doll; Nilufar Foadi; Florian Wegner; Andreas Leffler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-15       Impact factor: 3.000

9.  N-salicyloyltryptamine, a new anticonvulsant drug, acts on voltage-dependent Na+, Ca2+, and K+ ion channels.

Authors:  Démetrius Antonio Machado Araújo; Roberta Amaral Mafra; Andréia Laura Prates Rodrigues; Válter Miguel-Silva; Paulo Sérgio Lacerda Beirão; Reinaldo Nóbrega de Almeida; Lucindo Quintans; Maria Fátima Vanderlei de Souza; Jader Santos Cruz
Journal:  Br J Pharmacol       Date:  2003-12       Impact factor: 8.739

10.  Assessment of tracheal intubation in adults after induction with sevoflurane and different doses of propofol: a randomly controlled trial.

Authors:  Ping Li; LinLi Luo; Jian Wang; Wei Huang
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.